Ally Xu

Ally Xu has a diverse work experience in the field of regulatory affairs and quality management. Ally currently holds the position of Director Regulatory and Quality at HepQuant, starting in January 2022. Before that, they worked at CONMED Corporation as a Global Regulatory Affairs professional from September 2018 to February 2022. Prior to CONMED Corporation, Ally worked at Terumo BCT as a Global Regulatory Affairs professional from March 2017 to February 2022. Ally also gained experience at BD Medical - Pharmaceutical Systems as a Global Regulatory Affairs professional from April 2016 to February 2017. Additionally, Ally worked at Ferguson Biotechnologies LTD, where they served as a Project Consultant from January 2013 to February 2016 and as the VP Regulatory/General Manager from an unspecified date in 2010 to January 2013. Ally also held roles at Pearl River Consultants as a Project Manager from 2007 to 2009, at Baxter Healthcare in Regulatory Affairs from 2005 to 2006, and at the University of Southern California as a Consultant/Regulatory Distance Program Manager from 2004 to 2005. Ally's earlier work experience includes working as a Pharmacist/Drug Inspector at the Guandong Drug Control Institute of Chinese SFDA from July 1991 to November 1992.

Ally Xu is currently a Master candidate at the University of Southern California, studying Regulatory Science. Prior to this, they obtained a Bachelor's degree in Pharmacology from Fudan University. Ally also holds a Master's degree in Business Administration from the University of Southern California. In 2015, Ally obtained a Regulatory Affairs Certificate (RAC) from RAPS and the National Commission for Certifying Agencies (NCCA).